Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Blue Apron Holdings, Inc. - Class A Common Stock (NY: APRN )

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Blue Apron Holdings, Inc. - Class A Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Benzinga's Daily Brief On Trending Tickers For Feb. 9, 2022: Peloton, GameStop And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. 
Via Benzinga
Could Peloton Buy Blue Apron? Here's Why Citron's Andrew Left Says Yes
Peloton Interactive Inc (NASDAQ: PTON) could purchase meal kit service Blue Apron Holdings Inc (NYSE: APRN), Citron Research analyst Andrew Left said in a Tuesday note.&nbs 
Via Benzinga
Missfresh Tries To Tempt Investors With Value-Added Offerings
Key takeaways: • Missfresh has launched a series of value-added initiatives in its bid to achieve profitability by selling more higher-margin... 
Via Benzinga
Andrew Left: 'Things Have Changed For Short Sellers'
Investor Andrew Left was one of the central figures of the GameStop Corp (NYSE: GME) storyline in 2021. One year later, Left shared his thoughts on how things have changed for... 
Via Benzinga
Blue Apron Partners with Panasonic for Convenient Cooking Alternatives
From Blue Apron
Via Business Wire
APRN Stock Alert: Why Citron Thinks Blue Apron Can Go 4X
Meal-kit company Blue Apron saw a sizable uptick today after a Citron report sang its praises. How high can APRN stock go? 
Via InvestorPlace
Here's Why Blue Apron Is Trading Higher Today
Andrew Left's Citron Research issued a lengthy research report on Blue Apron Holdings Inc (NYSE: APRN) with a $40 price target. The price... 
Via Benzinga
New Year, New Healthy Food Option?
Picture credit: Ryan Concepcion on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing... 
Via Benzinga
Blue Apron to Release Fourth Quarter and Full Year 2021 Results on February 10
From Blue Apron Holdings, Inc.
Via Business Wire
Blue Apron Announces Plans For New Co-Branded Credit Card With Aspiration
From Blue Apron
Via Business Wire
50 Biggest Movers From Friday
Gainers SigmaTron International, Inc. (NASDAQ: SGMA) jumped 84.7% to settle at $14.94 on Friday after the company reported Q2 EPS and sales results were higher year over year.... 
Via Benzinga
36 Stocks Moving In Friday's Mid-Day Session
Gainers American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) jumped 43.1% to $2.6909. American Virtual Cloud Technologies shares jumped over 82% on Thursday after the company... 
Via Benzinga
3 Stocks That Didn't Crash Last Week
There weren't a lot of big winners last week, but these stocks posted double-digit gains as many of their peers went the wrong way. 
Via The Motley Fool
Blue Apron Recipes To Be Available On Amazon Alexa
Blue Apron Holdings Inc's (NYSE: APRN) recipes will be available with Amazon.Com Inc (NASDAQ: AMZN) Alexa, aiding home cooking and more culinary... 
Via Benzinga
Blue Apron Now Available with Amazon Alexa
From Blue Apron
Via Business Wire
US and Canadian Delivery Service to Acquire Another U.S. Delivery Services Company, Executes New Canadian Service Agreement in the Same Week
Image by mohamed Hassan via Pixabay The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Blue Apron Holdings's Return on Invested Capital Insights
Benzinga Pro data, Blue Apron Holdings (NYSE:APRN) reported Q3 sales of $109.65 million. Earnings fell to a loss of $19.34 million, resulting in a 57.16% decrease from last... 
Via Benzinga
Blue Apron Stock Falls On Q3 Miss, Gloomy Outlook
Blue Apron Holdings Inc (NYSE: APRN) reported a third-quarter FY21 net revenue decline of 2% year-on-year to $109.65 million, missing the consensus of $120.40... 
Via Benzinga
32 Stocks Moving in Tuesday's Pre-Market Session
Gainers Dover Motorsports, Inc. (NYSE: DVD) rose 57% to $3.58 in pre-market trading. Luminar Technologies, Inc. (NASDAQ: LAZR) rose 54.2% to $26.98 in pre-market trading after... 
Via Benzinga
Blue Apron Holdings, Inc. Reports Third Quarter 2021 Results
From Blue Apron Holdings, Inc.
Via Business Wire
5 Food Stocks To Watch Ahead Of This Week's Earnings: DoorDash, Wendy's And More
The COVID-19 pandemic has been a business-changing event for the restaurant industry and food-related businesses. With the reopening trade providing a lift to some businesses,... 
Via Benzinga
Exposures COVID-19
Blue Apron Announces Closing of Capital Raise
From Blue Apron Holdings, Inc.
Via Business Wire
7 Retail Stocks That Will Be Six Feet Under in 2022
Facing many challenges, expect these seven retail stocks to experience to a big drop in price over the next twelve months. 
Via InvestorPlace
Blue Apron to Release Third Quarter 2021 Results on November 9
From Blue Apron Holdings, Inc.
Via Business Wire
Is Blue Apron Stock a Buy?
The meal kit maker's business is gradually stabilizing. 
Via The Motley Fool
Blue Apron Announces Commencement of Fully Backstopped $45 Million Rights Offering
From Blue Apron Holdings, Inc.
Via Business Wire
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
Exposures Product Safety
28 Stocks Moving In Monday's Mid-Day Session
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical... 
Via Benzinga
Exposures Product Safety
35 Biggest Movers From Friday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for... 
Via Benzinga
Exposures Product Safety
Stocks Mixed as Debt Ceiling Optimism Trumps Jobs Report
Optimism surrounding the short-term debt ceiling deal is keeping losses in check, while the three major benchmarks are on pace for weekly wins. 
Via Talk Markets
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.